Global AI in Pathology Supply, Demand and Key Producers, 2024-2030

Publication ID:

GIR032405566

Publication Date:

March 11, 2024

Pages:

128

Publisher:

GIR

Countries:

Global [1]

USD 4,480.00

Software [2]

IT Services [3]

Computing & Electronics [4]

Description:

The global AI in Pathology market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The AI in Pathology market is a rapidly evolving segment within healthcare. Key aspects of the market include:
Image Analysis and Diagnosis:
AI technologies analyze pathology images, assisting pathologists in identifying patterns, anomalies, and potential markers for diseases.
Efficiency and Accuracy:
Automation through AI contributes to increased efficiency and accuracy in pathology diagnosis, reducing turnaround times and improving patient outcomes.
Integration with Laboratory Systems:
AI in pathology is integrated with laboratory information systems, allowing seamless workflow integration and data sharing.
AI in Pathology refers to the integration of Artificial Intelligence (AI) technologies in the field of pathology, which involves the study and diagnosis of diseases through the examination of tissues, cells, and body fluids. AI applications in pathology include image analysis, pattern recognition, and machine learning algorithms that aid pathologists in the interpretation of medical images, enhancing diagnostic accuracy and efficiency.
This report studies the global AI in Pathology demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI in Pathology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI in Pathology that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI in Pathology total market, 2019-2030, (USD Million)
Global AI in Pathology total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: AI in Pathology total market, key domestic companies and share, (USD Million)
Global AI in Pathology revenue by player and market share 2019-2024, (USD Million)
Global AI in Pathology total market by Type, CAGR, 2019-2030, (USD Million)
Global AI in Pathology total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global AI in Pathology market based on the following parameters 鈥� company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Koninklijke Philips N.V., F.Hoffmann-La Roche Ltd., Hologic, Inc., Visiopharm A/S, Paige AI, Inc., PathAI, Inc., Aiforia Technologies Plc, Indica Labs, Inc. and Optrascan, Inc. (Optra Ventures, LLC), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI in Pathology market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global AI in Pathology 麻豆原创, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global AI in Pathology 麻豆原创, Segmentation by Type
Convolutional neural networks (CNNs)
Generative adversarial networks (GANs)
Recurrent neural networks (RNNs)
Others
Global AI in Pathology 麻豆原创, Segmentation by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Reference Laboratories
Academic & Research Institutes
Companies Profiled:
Koninklijke Philips N.V.
F.Hoffmann-La Roche Ltd.
Hologic, Inc.
Visiopharm A/S
Paige AI, Inc.
PathAI, Inc.
Aiforia Technologies Plc
Indica Labs, Inc.
Optrascan, Inc. (Optra Ventures, LLC)
MindPeak GmbH
Key Questions Answered
1. How big is the global AI in Pathology market?
2. What is the demand of the global AI in Pathology market?
3. What is the year over year growth of the global AI in Pathology market?
4. What is the total value of the global AI in Pathology market?
5. Who are the major players in the global AI in Pathology market?

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Supply Summary
1.1 AI in Pathology Introduction
1.2 World AI in Pathology 麻豆原创 Size & Forecast (2019 & 2023 & 2030)
1.3 World AI in Pathology Total 麻豆原创 by Region (by Headquarter Location)
1.3.1 World AI in Pathology 麻豆原创 Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States AI in Pathology 麻豆原创 Size (2019-2030)
1.3.3 China AI in Pathology 麻豆原创 Size (2019-2030)
1.3.4 Europe AI in Pathology 麻豆原创 Size (2019-2030)
1.3.5 Japan AI in Pathology 麻豆原创 Size (2019-2030)
1.3.6 South Korea AI in Pathology 麻豆原创 Size (2019-2030)
1.3.7 ASEAN AI in Pathology 麻豆原创 Size (2019-2030)
1.3.8 India AI in Pathology 麻豆原创 Size (2019-2030)
1.4 麻豆原创 Drivers, Restraints and Trends
1.4.1 AI in Pathology 麻豆原创 Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI in Pathology Major 麻豆原创 Trends
2 Demand Summary
2.1 World AI in Pathology Consumption Value (2019-2030)
2.2 World AI in Pathology Consumption Value by Region
2.2.1 World AI in Pathology Consumption Value by Region (2019-2024)
2.2.2 World AI in Pathology Consumption Value Forecast by Region (2025-2030)
2.3 United States AI in Pathology Consumption Value (2019-2030)
2.4 China AI in Pathology Consumption Value (2019-2030)
2.5 Europe AI in Pathology Consumption Value (2019-2030)
2.6 Japan AI in Pathology Consumption Value (2019-2030)
2.7 South Korea AI in Pathology Consumption Value (2019-2030)
2.8 ASEAN AI in Pathology Consumption Value (2019-2030)
2.9 India AI in Pathology Consumption Value (2019-2030)
3 World AI in Pathology Companies Competitive Analysis
3.1 World AI in Pathology Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI in Pathology Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI in Pathology in 2023
3.2.3 Global Concentration Ratios (CR8) for AI in Pathology in 2023
3.3 AI in Pathology Company Evaluation Quadrant
3.4 AI in Pathology 麻豆原创: Overall Company Footprint Analysis
3.4.1 AI in Pathology 麻豆原创: Region Footprint
3.4.2 AI in Pathology 麻豆原创: Company Product Type Footprint
3.4.3 AI in Pathology 麻豆原创: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of 麻豆原创 Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: AI in Pathology Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI in Pathology 麻豆原创 Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: AI in Pathology Revenue 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: AI in Pathology Consumption Value Comparison
4.2.1 United States VS China: AI in Pathology Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: AI in Pathology Consumption Value 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.3 United States Based AI in Pathology Companies and 麻豆原创 Share, 2019-2024
4.3.1 United States Based AI in Pathology Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI in Pathology Revenue, (2019-2024)
4.4 China Based Companies AI in Pathology Revenue and 麻豆原创 Share, 2019-2024
4.4.1 China Based AI in Pathology Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI in Pathology Revenue, (2019-2024)
4.5 Rest of World Based AI in Pathology Companies and 麻豆原创 Share, 2019-2024
4.5.1 Rest of World Based AI in Pathology Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies AI in Pathology Revenue, (2019-2024)
5 麻豆原创 Analysis by Type
5.1 World AI in Pathology 麻豆原创 Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Convolutional neural networks (CNNs)
5.2.2 Generative adversarial networks (GANs)
5.2.3 Recurrent neural networks (RNNs)
5.2.4 Others
5.3 麻豆原创 Segment by Type
5.3.1 World AI in Pathology 麻豆原创 Size by Type (2019-2024)
5.3.2 World AI in Pathology 麻豆原创 Size by Type (2025-2030)
5.3.3 World AI in Pathology 麻豆原创 Size 麻豆原创 Share by Type (2019-2030)
6 麻豆原创 Analysis by Application
6.1 World AI in Pathology 麻豆原创 Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical & Biotechnology Companies
6.2.2 Hospitals & Reference Laboratories
6.2.3 Academic & Research Institutes
6.3 麻豆原创 Segment by Application
6.3.1 World AI in Pathology 麻豆原创 Size by Application (2019-2024)
6.3.2 World AI in Pathology 麻豆原创 Size by Application (2025-2030)
6.3.3 World AI in Pathology 麻豆原创 Size by Application (2019-2030)
7 Company Profiles
7.1 Koninklijke Philips N.V.
7.1.1 Koninklijke Philips N.V. Details
7.1.2 Koninklijke Philips N.V. Major Business
7.1.3 Koninklijke Philips N.V. AI in Pathology Product and Services
7.1.4 Koninklijke Philips N.V. AI in Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.1.5 Koninklijke Philips N.V. Recent Developments/Updates
7.1.6 Koninklijke Philips N.V. Competitive Strengths & Weaknesses
7.2 F.Hoffmann-La Roche Ltd.
7.2.1 F.Hoffmann-La Roche Ltd. Details
7.2.2 F.Hoffmann-La Roche Ltd. Major Business
7.2.3 F.Hoffmann-La Roche Ltd. AI in Pathology Product and Services
7.2.4 F.Hoffmann-La Roche Ltd. AI in Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.2.5 F.Hoffmann-La Roche Ltd. Recent Developments/Updates
7.2.6 F.Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
7.3 Hologic, Inc.
7.3.1 Hologic, Inc. Details
7.3.2 Hologic, Inc. Major Business
7.3.3 Hologic, Inc. AI in Pathology Product and Services
7.3.4 Hologic, Inc. AI in Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.3.5 Hologic, Inc. Recent Developments/Updates
7.3.6 Hologic, Inc. Competitive Strengths & Weaknesses
7.4 Visiopharm A/S
7.4.1 Visiopharm A/S Details
7.4.2 Visiopharm A/S Major Business
7.4.3 Visiopharm A/S AI in Pathology Product and Services
7.4.4 Visiopharm A/S AI in Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.4.5 Visiopharm A/S Recent Developments/Updates
7.4.6 Visiopharm A/S Competitive Strengths & Weaknesses
7.5 Paige AI, Inc.
7.5.1 Paige AI, Inc. Details
7.5.2 Paige AI, Inc. Major Business
7.5.3 Paige AI, Inc. AI in Pathology Product and Services
7.5.4 Paige AI, Inc. AI in Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.5.5 Paige AI, Inc. Recent Developments/Updates
7.5.6 Paige AI, Inc. Competitive Strengths & Weaknesses
7.6 PathAI, Inc.
7.6.1 PathAI, Inc. Details
7.6.2 PathAI, Inc. Major Business
7.6.3 PathAI, Inc. AI in Pathology Product and Services
7.6.4 PathAI, Inc. AI in Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.6.5 PathAI, Inc. Recent Developments/Updates
7.6.6 PathAI, Inc. Competitive Strengths & Weaknesses
7.7 Aiforia Technologies Plc
7.7.1 Aiforia Technologies Plc Details
7.7.2 Aiforia Technologies Plc Major Business
7.7.3 Aiforia Technologies Plc AI in Pathology Product and Services
7.7.4 Aiforia Technologies Plc AI in Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.7.5 Aiforia Technologies Plc Recent Developments/Updates
7.7.6 Aiforia Technologies Plc Competitive Strengths & Weaknesses
7.8 Indica Labs, Inc.
7.8.1 Indica Labs, Inc. Details
7.8.2 Indica Labs, Inc. Major Business
7.8.3 Indica Labs, Inc. AI in Pathology Product and Services
7.8.4 Indica Labs, Inc. AI in Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.8.5 Indica Labs, Inc. Recent Developments/Updates
7.8.6 Indica Labs, Inc. Competitive Strengths & Weaknesses
7.9 Optrascan, Inc. (Optra Ventures, LLC)
7.9.1 Optrascan, Inc. (Optra Ventures, LLC) Details
7.9.2 Optrascan, Inc. (Optra Ventures, LLC) Major Business
7.9.3 Optrascan, Inc. (Optra Ventures, LLC) AI in Pathology Product and Services
7.9.4 Optrascan, Inc. (Optra Ventures, LLC) AI in Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.9.5 Optrascan, Inc. (Optra Ventures, LLC) Recent Developments/Updates
7.9.6 Optrascan, Inc. (Optra Ventures, LLC) Competitive Strengths & Weaknesses
7.10 MindPeak GmbH
7.10.1 MindPeak GmbH Details
7.10.2 MindPeak GmbH Major Business
7.10.3 MindPeak GmbH AI in Pathology Product and Services
7.10.4 MindPeak GmbH AI in Pathology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.10.5 MindPeak GmbH Recent Developments/Updates
7.10.6 MindPeak GmbH Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 AI in Pathology Industry Chain
8.2 AI in Pathology Upstream Analysis
8.3 AI in Pathology Midstream Analysis
8.4 AI in Pathology Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

Companies Mentioned:

Koninklijke Philips N.V.
F.Hoffmann-La Roche Ltd.
Hologic, Inc.
Visiopharm A/S
Paige AI, Inc.
PathAI, Inc.
Aiforia Technologies Plc
Indica Labs, Inc.
Optrascan, Inc. (Optra Ventures, LLC)
MindPeak GmbH

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.